UW
SGMO

Unique Wealth’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Unique Wealth’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,950
Closed -$24.2K – 145
2024
Q3 		$24.2K Buy
27,950
+11,550
+70% +$8.46K 0.01% 120
2024
Q2 		$6.78K Buy
+16,400
New +$8.86K ﹤0.01% 92

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Unique Wealth's SGMO Position: Q4 2024 in Review

Unique Wealth sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2024, closing a stake of 27,950 shares — an estimated $24.2K sold.

Unique Wealth first reported a position in SGMO in Q2 2024 and held it in 2 quarters. The position peaked at $24.2K in Q3 2024. 128 funds tracked by Wall St. Rank hold SGMO as of Q4 2024.

  • Unique Wealth reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2024 after selling out during the quarter.
  • Unique Wealth sold 27,950 SANGAMO THERAPEUTICS INC shares in Q4 2024, an estimated $24.2K.
  • Unique Wealth first reported a position in SANGAMO THERAPEUTICS INC in Q2 2024 and held it in 2 quarters.
  • Unique Wealth's SANGAMO THERAPEUTICS INC position peaked at $24.2K in Q3 2024.
  • 128 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2024.

Based on Unique Wealth's 13F filing for Q4 2024, filed 13 Jan 2025.